ipscell.com
What Would be Your #1 Top FDA Reform on Stem Cells? Take our poll - The Niche
The FDA is faced with years of a static budget and a rapidly growing stem cell and cell therapy for-profit sector. Here's our poll.
Professor Paul Knoepfler, Ph.D.
